KIAA1549-BRAFFusions and IDH Mutations Can Coexist in Diffuse Gliomas of Adults-Reference-Cited by-同舟云学术

KIAA1549-BRAFFusions and IDH Mutations Can Coexist in Diffuse Gliomas of Adults

Published:2012-06-18 Issue:6 Volume:22 Page:841-847
ISSN:1015-6305
Container-title:Brain Pathology
language:en
Short-container-title:

Author:

Badiali Manuela,Gleize Vincent,Paris Sophie,Moi Loredana,Elhouadani Selma,Arcella Antonietta,Morace Roberta,Antonelli Manila,Buttarelli Francesca Romana,Figarella- Branger Dominique,Kim Young-Ho,Ohgaki Hiroko,Mokhtari Karima,Sanson Marc,Giangaspero Felice

Publisher

Wiley

Subject

Neurology (clinical),Pathology and Forensic Medicine,General Neuroscience

Reference23 articles.

1. Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas;Antonelli;J Neurooncol,2010

2. Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma;Bar;J Neuropathol Exp Neurol,2008

3. Mutations in CIC and FUBP1 contribute to human oligodendroglioma;Bettegowda;Science,2011

4. Association of chromosome 10 losses and negative prognosis in oligoastrocytomas;Bissola;Ann Neurol,2002

5. Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas;Forshew;J Pathol,2009

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring a distinct FGFR2::DLG5 rearrangement in a low-grade neuroepithelial tumor: A case report and mini-review of protein fusions in brain tumors;Journal of Neuropathology & Experimental Neurology;2024-06-04

2. Diffuse leptomeningeal glioneuronal tumor in a child masquerading as an intramedullary spinal pilocytic astrocytoma;Neuro-Oncology Advances;2023-01-01

3. Glioblastoma, IDH-Wildtype Harboring a KIAA1549::BRAF Fusion: Report of a Case With Comprehensive Molecular Profiling;Journal of Neuropathology & Experimental Neurology;2022-08-27

4. The oncogenic fusion landscape in pediatric CNS neoplasms;Acta Neuropathologica;2022-02-15

5. Central Nervous System Tumor Classification;Hematology/Oncology Clinics of North America;2022-02